Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Evotec SE Refines 2024 Guidance; Expects Revenues Of €790-820M, R&D Expenditures Of €50-60M, And Adjusted EBITDA Of €15-35M; Lower Guidance Due To Slower Sales Conversion And High Fixed Costs, But Business Transformation On Track For Sustainable Growth

Author: Benzinga Newsdesk | August 06, 2024 03:19pm

Posted In: EVO